Policy

Advertising policy

Peptide Authority's position on display advertising, sponsored content, and paid placement — what we do not run, what we would never run, and what the threshold would be if we ever introduced sponsored content.

Last reviewed: 2026-05-20

The current state

Peptide Authority runs no display advertising. The site does not load Google AdSense, programmatic ad networks, header bidding, or any third-party ad scripts. There are no banner ads, no in-content units, no auto-play video ads, no sticky-footer ads, and no exit-intent ad overlays.

Peptide Authority runs no sponsored content. No post, profile, guide, comparison, or claim review on this site has been paid for by an external party. There is no “sponsored by” content of any kind.

The one disclosed commercial relationship on the site is an affiliate link to Peptide Barn, covered in detail in our affiliate disclosure policy.

What we will never run

Some forms of advertising are permanently off-limits regardless of commercial pressure:

Advertising for any prescription-only medicine to the UK public. This is prohibited by Part 14 of the Human Medicines Regulations 2012 — the same rule that applies to clinics and pharmacies.
Advertising for any unlicensed medicine to the UK public — also prohibited under HMR 2012.
Display advertising for compounded GLP-1 supply, “research chemical” supply for human consumption, anti-doping substances, or weight-loss-clinic marketing that bypasses real clinical assessment.
Advertising paid for in cryptocurrency, gift cards, or other difficult-to-trace value transfers.
Display advertising on /safety-centre, /legal, trust pages, /policies, or any page where the reader is in a high-vulnerability moment (suspected counterfeit, suspected adverse event, considering a purchase).

If we ever introduced sponsored content

We currently have no plan to introduce sponsored content. If we ever did, the conditions would be:

The sponsored designation would appear above the fold on the sponsored page, in plain English, in equal type weight to the page title.
The sponsor would have no editorial review of the content. We would write what the evidence supports, including pointing out where the sponsor's product is unlicensed, unsupported, or inferior to alternatives.
The sponsor would have no veto over publication.
Sponsored content would never appear in the Safety Centre, the UK Law hub, the GLP-1 Centre, or trust / policy pages.
Sponsored content would never carry an evidence grade, a reviewer credit, or any element that could be mistaken for an editorial endorsement.
The introduction of sponsored content would itself trigger a major update to this advertising policy, an entry in the corrections log, and (per the brief) inclusion in an annual transparency report.

How to report a perceived breach

If a Peptide Authority page appears to be running advertising or sponsored content that we have not disclosed, please tell us via the corrections process. We treat undisclosed advertising as a serious error.

The current state

The one disclosed commercial relationship on the site is an affiliate link to Peptide Barn, covered in detail in our affiliate disclosure policy.

What we will never run

Some forms of advertising are permanently off-limits regardless of commercial pressure:

Advertising for any prescription-only medicine to the UK public. This is prohibited by Part 14 of the Human Medicines Regulations 2012 — the same rule that applies to clinics and pharmacies.

Advertising for any unlicensed medicine to the UK public — also prohibited under HMR 2012.

Display advertising for compounded GLP-1 supply, “research chemical” supply for human consumption, anti-doping substances, or weight-loss-clinic marketing that bypasses real clinical assessment.

Advertising paid for in cryptocurrency, gift cards, or other difficult-to-trace value transfers.

Display advertising on /safety-centre, /legal, trust pages, /policies, or any page where the reader is in a high-vulnerability moment (suspected counterfeit, suspected adverse event, considering a purchase).

If we ever introduced sponsored content

We currently have no plan to introduce sponsored content. If we ever did, the conditions would be:

The sponsored designation would appear above the fold on the sponsored page, in plain English, in equal type weight to the page title.

The sponsor would have no editorial review of the content. We would write what the evidence supports, including pointing out where the sponsor's product is unlicensed, unsupported, or inferior to alternatives.

The sponsor would have no veto over publication.

Sponsored content would never appear in the Safety Centre, the UK Law hub, the GLP-1 Centre, or trust / policy pages.

Sponsored content would never carry an evidence grade, a reviewer credit, or any element that could be mistaken for an editorial endorsement.

The introduction of sponsored content would itself trigger a major update to this advertising policy, an entry in the corrections log, and (per the brief) inclusion in an annual transparency report.